Luye Pharma Group

Luye Pharma Group company information, Employees & Contact Information

Luye Pharma Group is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications. The company has established R&D centers in China, the U.S. and Europe, with a robust pipeline of 40 drug candidates in China and more than 10 drug candidates overseas. Along with a number of new drugs and new formulations in the central nervous system and oncology therapeutic areas under study in the U.S. and Europe, Luye Pharma has reached high-level international standards in advanced drug delivery technologies including microspheres, liposomes and transdermal drug delivery systems, as well as actively making strategic developments in the fields of innovative new compounds and antibodies, gene & cell therapies and smart formulations. Luye Pharma is developing a global supply chain of 7 manufacturing sites with over 30 production lines in total, establishing GMP quality management and international standard control systems. With more than 30 products covering the 4 largest and fastest growing therapeutic areas — oncology, cardiovascular, metabolism and central nervous system, business is conducted in over 80 countries and regions around the world, including the largest pharmaceutical markets - China, the U.S., Europe and Japan, as well as in fast growing emerging markets.

Company Details

Employees
750
Founded
-
Address
3f D-Site, 2272 Hongqiao Road, Shanghai,200336,china
Phone
86 53 5671 7618
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
luye.cn
HQ
Shanghai
Looking for a particular Luye Pharma Group employee's phone or email?

Luye Pharma Group Questions

News

FDA Approves Erzofri for the Treatment of Schizophrenia and Schizoaffective Disorder - Psychiatric Times

FDA Approves Erzofri for the Treatment of Schizophrenia and Schizoaffective Disorder Psychiatric Times

Luye Pharma Grants Exclusive Promotion Rights to Moksha8, Deepening Strategic Presence in Latin America for CNS Business - PR Newswire

Luye Pharma Grants Exclusive Promotion Rights to Moksha8, Deepening Strategic Presence in Latin America for CNS Business PR Newswire

Luye Pharma and Duopharma Reach Strategic Partnership to Expand Accessibility of Cholesterol Management Products in Malaysia - PR Newswire APAC - 美通社

Luye Pharma and Duopharma Reach Strategic Partnership to Expand Accessibility of Cholesterol Management Products in Malaysia - PR Newswire APAC 美通社

Luye Pharma Enters Local Seroquel® Distribution and Marketing Partnership with ICI Pakistan Limited - 팜뉴스

Luye Pharma Enters Local Seroquel® Distribution and Marketing Partnership with ICI Pakistan Limited 팜뉴스

Characterization of enteric-coated erythromycin tablets by Raman mapping and its pharmaceutical evaluation - Frontiers

Characterization of enteric-coated erythromycin tablets by Raman mapping and its pharmaceutical evaluation Frontiers

Luye Medical to buy Australia's Healthe Care for $688 million - China Daily

Luye Medical to buy Australia's Healthe Care for $688 million China Daily

Luye Medical welcomes Australia's Healthe Care to its Group - ACN Newswire

Luye Medical welcomes Australia's Healthe Care to its Group ACN Newswire

Top Luye Pharma Group Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant